[1P-0629] A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer

〇Ting-Yu Chang^1,2、Jen-Liang Su^1,3,4,5 (1.National Institute of Cancer Research, National Health Research Institutes, Taiwan, ROC.、2.Graduate Institute of Toxicology, National Taiwan University Medical College, Taiwan, ROC.、3.Center for Molecular Medicine, China Medical University Hospital, Taiwan, ROC.、4.Graduate Institute of Cancer Biology, China Medical University, Taiwan, ROC.、5.Department of Biotechnology, Asia University, Taiwan, ROC.)

EGFR-TKI, E1A, breast cancer